These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12763926)

  • 1. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
    Deaglio S; Capobianco A; Bergui L; Dürig J; Morabito F; Dührsen U; Malavasi F
    Blood; 2003 Sep; 102(6):2146-55. PubMed ID: 12763926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
    Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F
    Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
    Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
    Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
    Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow.
    Jaksic O; Paro MM; Kardum Skelin I; Kusec R; Pejsa V; Jaksic B
    Blood; 2004 Mar; 103(5):1968-9. PubMed ID: 14976064
    [No Abstract]   [Full Text] [Related]  

  • 6. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL.
    Pittner BT; Jelinek DF; Kay NE
    Leukemia; 2004 Jan; 18(1):180-2. PubMed ID: 14523466
    [No Abstract]   [Full Text] [Related]  

  • 7. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
    Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
    Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
    Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
    Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD38 modifications in chronic lymphocytic leukemia: are they relevant?
    Ghia P; Guida G; Scielzo C; Geuna M; Caligaris-Cappio F
    Leukemia; 2004 Oct; 18(10):1733-5. PubMed ID: 15343349
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF).
    Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T
    Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
    Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP
    Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
    Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
    Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
    Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
    Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipid microdomains mediate CD38 internalization: topography of the endocytosis.
    Trubiani O; Guarnieri S; Orciani M; Salvolini E; Di Primio R
    Int J Immunopathol Pharmacol; 2004; 17(3):293-300. PubMed ID: 15461863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression.
    McCabe D; Bacon L; O'Regan K; Condron C; O'Donnell JR; Murphy PT
    Leukemia; 2004 Mar; 18(3):649-50. PubMed ID: 14749705
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia.
    Manna A; Aulakh S; Jani P; Ahmed S; Akhtar S; Coignet M; Heckman M; Meghji Z; Bhatia K; Sharma A; Sher T; Alegria V; Malavasi F; Chini EN; Chanan-Khan A; Ailawadhi S; Paulus A
    Clin Cancer Res; 2019 Jul; 25(13):3974-3985. PubMed ID: 30940652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.